Adler, A.I., Ting, S., Dent, R. et al. (1 more author) (2019) NICE guidance on dapagliflozin with insulin for type 1 diabetes. The Lancet Diabetes & Endocrinology, 7 (10). pp. 750-751. ISSN 2213-8587
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2019 Elsevier. This is an author produced version of a paper subsequently published in Lancet Diabetes and Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 19 Sep 2019 13:14 |
Last Modified: | 19 Sep 2019 13:14 |
Status: | Published |
Publisher: | Elsevier |
Refereed: | Yes |
Identification Number: | 10.1016/s2213-8587(19)30265-7 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:151121 |
Download
Filename: Dapagliflozin for Type 1 Diabetes Lancet v0.15 AA [ACIC] (1).pdf
Licence: CC-BY-NC-ND 4.0